HERB-PARTITIONED MOXIBUSTION AND ACUPUNCTURE FOR THE TREATMENT OF ACTIVE CROHN'S DISEASE:A RANDOMIZED CONTROLLED TRIAL

被引:0
|
作者
Huangan Wu [1 ]
Chunhui Bao [2 ]
Huirong Liu [1 ]
Jimeng Zhao [2 ]
Yuan Lu [2 ]
Yifang Zhu [2 ]
Yin Shi [1 ]
Zhijun Weng [1 ]
Hui Feng [3 ]
Xin Guan [4 ]
Jing Li [5 ]
Weifeng Chen [6 ]
Luyi Wu [7 ]
Xiaoming Jin [8 ]
Chuanzi Dou [1 ]
机构
[1] Shanghai Institute of Acupuncture-Moxibustion and Meridian
[2] Shanghai University of Traditional Chinese Medicine
[3] Shanghai Guanghua Hospital of Integrated Chinese and Western Medicine
[4] Shuguang Hospital,Shanghai University of Traditional Chinese Medicine
[5] Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine
[6] Zhongshan Hospital,Fudan University
[7] Qigong Institute,Shanghai University of Traditional Chinese Medicine
[8] Stark Neurosciences Research Institute,Indiana University School of Medicine
关键词
HERB-PARTITIONED MOXIBUSTION AND ACUPUNCTURE FOR THE TREATMENT OF ACTIVE CROHN’S DISEASE;
D O I
暂无
中图分类号
R246.1 [内科];
学科分类号
100512 ;
摘要
Background: Acupuncture and moxibustion are often used as an alternative therapy for Crohn’s disease(CD), however, their efficacy are not fully established.Objective: This study sought to evaluate the clinical efficacy and safety of acupuncture and moxibustion for the treatment of active CD of mild to moderate severity.Methods: Ninety-two patients were equally and randomly divided into a treatment group that received herb-partitioned moxibustion combined with acupuncture and a control group that received wheat bran-partitioned moxibustion combined with shallow acupuncture.The patients received 3 treatment sessions per week for 12 weeks, and were followed up at the 24 th week.The outcomes were measured by using the CD Activity Index(CDAI) score, lab tests, endoscopic rating, and intestinal histology.Results: The CDAI scores of both the treatment and control groups were significantly reduced after treatment compared to that prior to treatment, but the improvement of the treatment group was significant better than that of the control group.The symptom improvement in patients of the treatment group was sustained at the follow-up, while that of the control group was not.Both groups showed significantly improvement in quality of life ratings after treatments, but the improvement was significantly better in the treatment group than in the control group.In addition, the patients in the treatment group showed significantly increased hemoglobin and decreased C-reactive protein and histopathological scores at the end of the treatment, while the control group did not show any changes.Conclusion: Acupuncture and moxibustion are effective and safe treatment methods for mild to moderate CD.In addition to the placebo effect, acupuncture also has significant therapeutic effects.
引用
收藏
页码:222 / 222
页数:1
相关论文
共 50 条
  • [31] Moxibustion treatment for Parkinson’s disease: study protocol for a randomized controlled trial
    Chunxiao Wu
    Lijun Zhao
    Yuelin Guo
    Xiaoqian Hao
    Yaohua Fan
    Peipei Wu
    Jiajun Han
    Qinglian Li
    Xiaoling Wang
    Qizhang Wang
    Xiaodong Luo
    Meiling Zhu
    BMC Complementary Medicine and Therapies, 23
  • [32] Moxibustion treatment for Parkinson's disease: study protocol for a randomized controlled trial
    Wu, Chunxiao
    Zhao, Lijun
    Guo, Yuelin
    Hao, Xiaoqian
    Fan, Yaohua
    Wu, Peipei
    Han, Jiajun
    Li, Qinglian
    Wang, Xiaoling
    Wang, Qizhang
    Luo, Xiaodong
    Zhu, Meiling
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [33] Acupuncture and moxibustion as complementary therapy in Crohn's disease
    Joos, S.
    Brinkhaus, B.
    Maluche, C.
    Maupai, N.
    Kohnen, R.
    Hahn, E.
    Schuppan, D.
    DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR, 2005, 48 (01): : 6 - 17
  • [34] Effect of herb-partitioned moxibustion in improving tight junctions of intestinal epithelium in Crohn disease mediated by TNF-α-NF-κB-MLCK pathway
    Gao Yan-ling
    Wang Yu-ning
    Guo Ya-jing
    Sun Yi
    Wang Yi-ran
    Zhou Jing
    Zhao Ji-meng
    Wu Huan-gan
    Shi Yin
    JOURNAL OF ACUPUNCTURE AND TUINA SCIENCE, 2021, 19 (01) : 19 - 29
  • [35] Randomized controlled trial of clarithromycin & ethambutol in the treatment of Crohn's disease
    Goodgame, RW
    Kimball, K
    Graham, DY
    Ou, CN
    GASTROENTEROLOGY, 1999, 116 (04) : A725 - A725
  • [36] Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohn's disease
    Goodgame, RW
    Kimball, K
    Akram, S
    Ike, E
    Ou, CN
    Sutton, F
    Graham, D
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (12) : 1861 - 1866
  • [37] Acupuncture and moxibustion for the elderly patients with depression: A randomized controlled trial
    Gong, Juanfen
    Fan, Ling
    Chen, Zhao
    Fu, Wenbin
    WORLD JOURNAL OF ACUPUNCTURE-MOXIBUSTION, 2019, 29 (03) : 169 - 173
  • [38] Acupuncture and moxibustion for the elderly patients with depression:A randomized controlled trial
    龚娟芬
    樊凌
    陈昭
    符文彬
    WorldJournalofAcupuncture-Moxibustion, 2019, 29 (03) : 169 - 173
  • [39] Version of Breech Fetuses by Moxibustion With Acupuncture A Randomized Controlled Trial
    Coulon, Capucine
    Poleszczuk, Marion
    Paty-Montaigne, Marie-Helene
    Gascard, Cecile
    Gay, Charlotte
    Houfflin-Debarge, Veronique
    Subtil, Damien
    OBSTETRICS AND GYNECOLOGY, 2014, 124 (01): : 32 - 39
  • [40] Acupuncture and moxibustion in the treatment of ulcerative colitis: A randomized controlled study
    Joos, Stefanie
    Wildau, Nicole
    Kohnen, Ralf
    Szecsenyi, Joachim
    Schuppan, Detlef
    Willich, Stefan N.
    Hahn, Eckhart G.
    Brinkhaus, Benno
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2006, 41 (09) : 1056 - 1063